ACADIA Pharmaceuticals Inc —— 季度财务数据 (NASDAQ:ACAD) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 40.38 M20.32 M63.96 M74.29 M-48.73 M 109.84 M 投资活动产生的现金 122.15 M-124.05 M-43.29 M-79.35 M-55.87 M -302.56 M 融资活动产生的现金 1.97 M1.84 M15.96 M9.42 M22.67 M 49.88 M 自由现金流 39.93 M-78.52 M63.96 M73.9 M-52.74 M 6.61 M

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

新闻

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

JAZZ or ACAD: Which Is the Better Value Stock Right Now?

Acadia Pharmaceuticals任命Jonathan M. Poole为董事会成员

Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

美国银行因欧盟挫折下调Acadia Pharmaceuticals目标价